ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Sumitomo Chemical to take stake in nucleic acid startup

Japanese companies joining race to develop next-generation biomedicines

Sumitomo Chemical produces pharmaceutical intermediaries at a plant in Osaka.

TOKYO -- Japan's Sumitomo Chemical will make inroads into the emerging field of nucleic acid-based medicines, investing 4 billion yen ($35.7 million) in a domestic upstart.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more